SCA research looks promising. But what about my life today?

You see your specialist once or twice a year. In between, your condition continues. Symptoms shift. Fatigue patterns change. A fall happens. You adapt your home. You try something that helps with balance — and wonder if anyone else has tried it too.

All of that knowledge exists only in your head, in scattered notes, in conversations with people who love you. It doesn't reach your clinical team. And when you finally sit in the consultation room — exhausted, perhaps anxious — you struggle to recall the details that would make the difference.

You — who know more about living with your disease than anyone else in the room — leave with a sense that you didn't get to tell the whole story.

Living with SCA means noticing things constantly and being able to act on them almost never. You know a grab rail needs ordering. A benefit application needs filing. A letter to your employer needs writing. A referral needs requesting.

But you are also managing fatigue, cognitive load, and a body that makes every administrative task harder than it should be. So the observation sits in your head. The letter doesn't get written. The application misses its window.

The gap between knowing what needs doing and having the capacity to do it is where agency goes. Over time, this erodes not just practical outcomes but self-perception: the person who notices stops seeing themselves as someone whose observations have value.

Progressive disease doesn't just take physical function. It quietly drains household finances in ways that accumulate invisibly until they become a crisis.

Reduced working hours. Equipment costs your insurance doesn't cover. Home modifications. Travel to specialists who are never local. The partner who cuts back their own hours to provide care — and loses their own pension contributions in the process.

And then the system that's supposed to help requires exactly the kind of sustained, detail-heavy administrative effort that your condition makes hardest to produce. The forms are long. The deadlines are rigid. And on the days when you have the cognitive energy to tackle them, you also have twelve other things competing for that same limited resource.

The caregiver who notices the subtle gait change. Who tracks the slow decline in speech clarity from one month to the next. Who manages the medication schedule and the benefit applications and the home adaptations. Their knowledge exists nowhere in the clinical or research record.

They carry the observational burden of progressive disease with no structured outlet, no professional acknowledgement, and no support infrastructure designed for their specific perspective. Caregiving generates its own expertise — but the system treats it as invisible.

Many SCAs are hereditary. Which means someone in your family — a child, a sibling, a niece — may be carrying the same gene.

Should they get tested? When? What do you tell a teenager? How do you prepare someone for a possibility you barely know how to carry yourself?

There is no structured guidance for navigating this. No collection of experiences from families who've already had this conversation — what they said, when they said it, what they wish they'd done differently. Wimly won't make that conversation easy. Nothing can. But it can make sure you're not the first family to face it without support.

Every day, families living with SCA navigate the same practical questions — how to manage balance on bad days, when to start using mobility support, how to talk to children about what's happening, how to plan around unpredictable energy levels, how to prepare for short appointments.

Somewhere in the world, another family has already faced every one of those questions. Figured things out through trial, error, and necessity. But there's no way to find them — because that knowledge lives inside one person's experience, invisible to everyone else.

The practical insight that would save a newly diagnosed family months of hard learning is out there. But no one has built a way to capture it, organise it, or put it in front of the next person who needs it.

You are generating research data every single day. You just don't know it — and neither does anyone in a position to use it.

The fatigue pattern that follows exertion by two days, not one. The speech changes that are worse in the afternoon but clear in the morning. The medication side effect that lasted three weeks and then resolved. These are not casual impressions — they are precise, repeatable, behaviourally rich observations, more granular than anything a clinical assessment captures in a thirty-minute appointment.

Collectively, across the global SCA community, these observations represent the largest untapped source of real-world evidence in rare disease. But none of it reaches researchers. It evaporates in memory, in scattered notes, in conversations no one records.